Based in Spain, BioClonal specializes in developing monoclonal antibodies tailored to your project’s needs, regardless of how challenging the target may be. With our proprietary RedMabs platform, we make the undruggable druggable, providing custom antibody solutions to help you achieve your therapeutic goals.
All work is carried out in our state-of-the-art facilities here in Spain. Our success-based payment model ensures that you only pay when we deliver results, and our royalty-free service guarantees that you retain full ownership of your intellectual property at all times.
If you have a monoclonal antibody in mind, let us help you turn it into reality. To know more
